Serina Therapeutics, Inc. SEC filings SER

Serina Therapeutics, Inc. has 519 filings in SEC EDGAR's recent list, going back to Jul 10, 2017. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.

Serina Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Bylaw or fiscal year change
Oct 9, 2026 Oct 5, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
8-K Current report
Material agreement, Unregistered share sale
Aug 27, 2026 Aug 21, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Officer or director change
Jul 23, 2026 Jul 19, 2026
8-K Current report
Officer or director change
Jul 22, 2026 Jul 22, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 24, 2026 Jun 17, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change
Apr 21, 2026 Apr 15, 2026
8-K Current report
Results of operations
Mar 25, 2026 Mar 25, 2026
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Mar 23, 2026 Mar 17, 2026
8-K Current report
Other events
Jan 28, 2026 Jan 27, 2026
8-K Current report
Listing notice, Regulation FD disclosure
Jan 15, 2026 Jan 9, 2026
8-K Current report
Other events
Dec 10, 2025 Dec 10, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Shareholder vote results
Nov 12, 2025 Nov 7, 2025
8-K Current report
Other events
Nov 3, 2025 Nov 3, 2025
8-K Current report
Other events
Oct 6, 2025 Oct 6, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Sep 15, 2025 Sep 9, 2025
8-K Current report
Regulation FD disclosure
Sep 9, 2025 Sep 9, 2025
8-K Current report
Other events
Aug 25, 2025 Aug 25, 2025
8-K Current report
Bylaw or fiscal year change
Aug 22, 2025 Aug 18, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Jul 29, 2025 Jul 29, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 1, 2025 Jul 1, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
May 22, 2025 May 22, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Material agreement, Other events
Apr 29, 2025 Apr 25, 2025
8-K Current report
Regulation FD disclosure
Apr 15, 2025 Apr 15, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Apr 14, 2025 Apr 8, 2025
8-K Current report
Regulation FD disclosure
Apr 7, 2025 Apr 7, 2025
8-K Current report
Results of operations
Mar 24, 2025 Mar 24, 2025
8-K Current report
Regulation FD disclosure
Mar 24, 2025 Mar 24, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 12, 2025 Feb 11, 2025
8-K Current report
Regulation FD disclosure
Feb 3, 2025 Feb 3, 2025
8-K Current report
Officer or director change
Jan 15, 2025 Jan 14, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 6, 2025 Jan 6, 2025
8-K Current report
Material agreement, Acquisition or sale of assets
Dec 26, 2024 Dec 23, 2024
8-K Current report
Officer or director change, Shareholder vote results
Dec 18, 2024 Dec 13, 2024
8-K Current report
Regulation FD disclosure
Dec 11, 2024 Dec 11, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 2, 2024 Nov 26, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure
Oct 2, 2024 Oct 2, 2024
8-K Current report
Officer or director change
Sep 12, 2024 Sep 8, 2024
8-K Current report
Regulation FD disclosure
Sep 5, 2024 Sep 4, 2024
8-K Current report
Officer or director change
Aug 16, 2024 Aug 12, 2024
8-K Current report
Results of operations
Aug 9, 2024 Aug 9, 2024
8-K Current report
Regulation FD disclosure
Jul 29, 2024 Jul 29, 2024
8-K Current report
Officer or director change, Other events
Jul 18, 2024 Jul 15, 2024
8-K Current report
Officer or director change
Jul 12, 2024 Jul 9, 2024
8-K Current report
Other events
Jun 10, 2024 Jun 6, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Auditor change
May 3, 2024 Apr 29, 2024
8-K Current report
Officer or director change
Apr 17, 2024 Apr 12, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
Apr 1, 2024 Mar 26, 2024
8-K Current report
Results of operations
Mar 22, 2024 Mar 22, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Mar 14, 2024 Mar 14, 2024
8-K Current report
New debt, Other events
Mar 7, 2024 Mar 5, 2024
8-K Current report
Material agreement, New debt
Feb 14, 2024 Feb 9, 2024
8-K Current report
New debt, Unregistered share sale, Change in control, Other events
Feb 6, 2024 Feb 1, 2024
8-K Current report
New debt
Jan 19, 2024 Jan 16, 2024
8-K Current report
Officer or director change
Jan 11, 2024 Jan 8, 2024
8-K Current report
New debt
Jan 5, 2024 Jan 3, 2024
8-K Current report
New debt
Dec 28, 2023 Dec 21, 2023
8-K Current report
Shareholder vote results
Dec 18, 2023 Dec 13, 2023
8-K Current report
New debt
Dec 8, 2023 Dec 5, 2023
8-K Current report
Agreement ended, Officer or director change
Dec 1, 2023 Nov 27, 2023
8-K Current report
New debt, Other events
Nov 17, 2023 Nov 15, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
New debt
Nov 6, 2023 Oct 31, 2023
8-K Current report
New debt
Oct 6, 2023 Oct 3, 2023
8-K Current report
New debt
Sep 15, 2023 Sep 11, 2023
8-K Current report
Officer or director change
Sep 8, 2023 Sep 1, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Aug 30, 2023 Aug 29, 2023
8-K Current report
New debt
Aug 25, 2023 Aug 22, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
8-K Current report
Material agreement, New debt
Aug 4, 2023 Jul 31, 2023
8-K Current report
Listing notice, Regulation FD disclosure
Jul 25, 2023 Jul 24, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Regulation FD disclosure
Jul 21, 2023 Jul 21, 2023
8-K Current report
New debt
Jul 7, 2023 Jul 5, 2023
8-K Current report
Material agreement, New debt
Jun 8, 2023 Jun 2, 2023
8-K Current report
New debt, Listing notice
May 23, 2023 May 17, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
8-K Current report
Listing notice
Apr 26, 2023 Apr 20, 2023
8-K Current report
New debt, Unregistered share sale
Apr 6, 2023 Apr 4, 2023
8-K Current report
Results of operations
Mar 31, 2023 Mar 31, 2023
8-K Current report
Material agreement, New debt, Officer or director change
Mar 15, 2023 Mar 9, 2023
8-K Current report
New debt, Unregistered share sale
Feb 17, 2023 Feb 15, 2023
8-K Current report
Material agreement
Feb 10, 2023 Feb 9, 2023
8-K Current report
New debt, Unregistered share sale
Jan 27, 2023 Jan 25, 2023
8-K Current report
New debt, Unregistered share sale
Dec 16, 2022 Dec 14, 2022
8-K Current report
Officer or director change, Shareholder vote results
Dec 12, 2022 Dec 7, 2022
8-K Current report
Listing notice
Nov 25, 2022 Nov 22, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
New debt, Unregistered share sale
Oct 21, 2022 Oct 21, 2022
8-K Current report
New debt, Unregistered share sale
Aug 19, 2022 Aug 16, 2022
8-K Current report
Results of operations
Aug 12, 2022 Aug 12, 2022
8-K Current report
New debt, Unregistered share sale
Jun 10, 2022 Jun 6, 2022
8-K Current report
Other events
May 18, 2022 May 13, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
8-K Current report
New debt, Unregistered share sale
Apr 6, 2022 Apr 4, 2022
8-K Current report
Results of operations
Mar 29, 2022 Mar 29, 2022
8-K Current report
Officer or director change
Mar 3, 2022 Feb 25, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale
Feb 15, 2022 Feb 14, 2022
8-K Current report
New debt, Unregistered share sale
Feb 4, 2022 Jan 31, 2022
8-K Current report
Officer or director change, Shareholder vote results
Dec 30, 2021 Dec 29, 2021
8-K Current report
New debt
Dec 9, 2021 Dec 6, 2021
8-K Current report
Listing notice
Nov 23, 2021 Nov 17, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
8-K Current report
Material agreement
Nov 9, 2021 Nov 8, 2021
8-K Current report
New debt
Oct 26, 2021 Oct 25, 2021
8-K Current report
New debt
Sep 3, 2021 Aug 31, 2021
8-K Current report
Results of operations
Aug 13, 2021 Aug 13, 2021
8-K Current report
Other events
Jul 23, 2021 Jul 23, 2021
8-K Current report
New debt, Auditor change
Jul 20, 2021 Jul 12, 2021
8-K Current report
New debt
May 25, 2021 May 24, 2021
8-K Current report
Results of operations
May 17, 2021 May 17, 2021
8-K Current report
Results of operations
Mar 31, 2021 Mar 31, 2021
8-K Current report
Acquisition or sale of assets
Mar 19, 2021 Mar 15, 2021
8-K Current report
Material agreement
Mar 8, 2021 Mar 6, 2021
8-K Current report
Other events
Mar 2, 2021 Mar 2, 2021
8-K Current report
Material agreement
Feb 11, 2021 Feb 10, 2021
8-K Current report
New debt, Unregistered share sale
Jan 29, 2021 Jan 25, 2021
8-K Current report
New debt, Unregistered share sale
Jan 7, 2021 Jan 4, 2021
8-K Current report
Other events
Jan 5, 2021 Jan 1, 2021
8-K Current report
Shareholder vote results
Dec 29, 2020 Dec 28, 2020
8-K Current report
Results of operations
Nov 16, 2020 Nov 16, 2020
8-K Current report
New debt, Unregistered share sale
Nov 10, 2020 Nov 9, 2020
8-K Current report
New debt, Unregistered share sale
Sep 18, 2020 Sep 15, 2020
8-K Current report
Results of operations
Aug 14, 2020 Aug 14, 2020
8-K Current report
New debt, Unregistered share sale
Jul 30, 2020 Jul 27, 2020
8-K Current report
New debt
Jun 12, 2020 Jun 11, 2020
8-K Current report
Listing notice
Jun 5, 2020 Jun 1, 2020
8-K Current report
New debt, Officer or director change
May 21, 2020 May 15, 2020
8-K Current report
Results of operations
May 14, 2020 May 14, 2020
8-K Current report
Exit or restructuring costs
Apr 30, 2020 Apr 24, 2020
8-K Current report
Results of operations
Mar 31, 2020 Mar 30, 2020
8-K Current report
Officer or director change
Mar 16, 2020 Mar 12, 2020
8-K Current report
Shareholder vote results
Jan 6, 2020 Dec 30, 2019
8-K Current report
New debt
Dec 26, 2019 Dec 18, 2019
8-K Current report
Results of operations
Nov 14, 2019 Nov 14, 2019
8-K Current report Oct 18, 2019 Oct 18, 2019
8-K Current report
Agreement ended
Oct 3, 2019 Sep 30, 2019
8-K Current report
Regulation FD disclosure
Sep 9, 2019 Sep 9, 2019
8-K Current report
Results of operations
Aug 14, 2019 Aug 14, 2019
8-K Current report
Officer or director change
Aug 5, 2019 Jul 30, 2019
8-K Current report
Results of operations
May 15, 2019 May 15, 2019
8-K Current report
Results of operations
Apr 1, 2019 Apr 1, 2019
8-K Current report
Material agreement
Mar 27, 2019 Mar 21, 2019
8-K Current report
Unregistered share sale
Mar 22, 2019 Mar 18, 2019
8-K Current report
Officer or director change
Mar 15, 2019 Mar 11, 2019
8-K Current report
Material agreement, Officer or director change, Other events
Mar 7, 2019 Mar 1, 2019
8-K Current report
Regulation FD disclosure
Nov 29, 2018 Nov 29, 2018

Showing 153 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SER (NYSE)
Fiscal year ends
December 31
Incorporated in
AL
Headquarters
Huntsville, AL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1708599
Former names
AgeX Therapeutics, Inc. (until Apr 1, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.